Q Fever Market Share

  • Report ID: 4118
  • Published Date: Aug 13, 2024
  • Report Format: PDF, PPT

Q Fever Market Share

Regionally, the global Q fever market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is estimated to account for largest revenue share by 2036, due to increasing awareness of infectious diseases, growing demand for enhanced diagnostic facilities, and a higher prevalence of Q fever in the region. The rising cases of diseases related to acute Q fever, such as, Rocky Mountain spotted fever, West Nile virus, and Lyme disease are observed in the region which is further estimated to hike the growth of the market in the region over the forecast period. According to data released by the Centers for Disease Control and Prevention (CDC), in 2019, 178 cases of acute Q fever, and 34 cases of chronic Q fever were reported in the United States. These are the significant factors to boost the growth of the market in the region. Furthermore, the global Q fever market is also projected to witness modest growth in the Asia Pacific region over the forecast period on the back of the growing number of cattle, increasing geriatric population with low immunity, and rising cases of Q fever. For instance, about 20% of Indians suffer from low immunity.

Research Nester
Q-Fever-Market-Growth
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4118
  • Published Date: Aug 13, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of Q fever is assessed at USD 548.92 million.

Q Fever Market size was valued at USD 527.4 million in 2023 and is likely to reach USD 1 billion by 2036, registering around 5.1% CAGR during the forecast period i.e., between 2024-2036. Growing patient pool on account of the higher prevalence of Q fever, rising demand for enhanced diagnostic solutions, and increasing awareness of acute & chronic Q fever prevention will propel the market growth.

North America industry is estimated to account for largest revenue share by 2036, due to increasing awareness of infectious diseases, growing demand for enhanced diagnostic facilities, and a higher prevalence of Q fever in the region.

The major players in the market are Pfizer Inc., Arix Bioscience plc, Yashica Pharmaceuticals Pvt. Ltd, Merck KGaA, Melinta Therapeutics LLC, Teva Pharmaceutical Ltd., Bayer AG, and Johnson & Johnson Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample